SANOFI AVENTIS PHARMACEUTICALS

1. AMARJIT SINGH ID No. MHS1007002

2. INTRODUCTION Multinational Pharmaceuticals Company. World’s 4th Largest. Founded in 20 August 2004. Head Quarter- Paris, France.

3. INTRODUCTION CE0 - Chris Viehbacher CHAIRMAN - Jean Francois Dehecq REVENUE - € 29.31 billion (2009) PROFIT - € 5.265 billion (2009)

4. INTRODUCTION It is a Member of- European Federation of Pharmaceutical Industries & Associations (EFPIA).

5. GENERAL INFORMATION Revenue - €29.31billion (2009) Operating Income - €6.366billion (2009) Profit - €5.265billion (2009) Market Share - 4.3% Employees - 104,870 (2009)

6. WHAT BUSINESS ARE THEY IN Manufacturing & Marketing of Pharmaceutical Products. Over the Counter Medication. Research & Development.

8. Central Nervous System

9. Diabetes

10. Internal Medicine

11. Oncology

12. Thrombosis

14. POSITIONING LANTUS Adult and pediatric patients with type 1 diabetes mellitus . Adult patients with type 2 diabetesmellitus

15. TOP PHARMACEUTICAL COMPANIES WITH REVENUES AS PER 2009 ANNUAL REPORT Johnson & Johnson (U.S.) - $ 6,190 Pfizer (U.S.) - $ 5,001 Roche (Switzerland) - $4,735 Glaxo Smith Kline (U.K.) - $4,583 Novartis (Switzerland) - $4,427 Sanofi Aventis (France) - $4,199

16. MARKET SHARE OF DIFFERENT COMPANIES

17. MAJOR COMPETITORS IN U.S.A. Johnson & Johnson Pfizer Glaxo Smith Kline Bristol-Myers Squibb Astra Zeneca

18. BRISTOL-MYERS SQUIBB Founded in - 1989 Revenue - $18.8 billion(2009) Operating Income - $5.34 billion(2009) Employee’s - 28,000 (2009)

19. MAIN PRODUCTIONS AREAS INCLUDE Cancer HIV/AIDS Cardiovascular disease Diabetes Hepatitis Rheumatoid Arthritis & Psychiatric disorders.

20. DISTRIBUTION ALL OVER THE WORLD

21. POSITIONING OF MEDICINE FOR DIABETES ONGLYZA™ (saxagliptin) is the main product for diabetes. Developed and marketed through a collaboration with AstraZeneca. For the treatment of type 2 diabetes in adults.

22. JOHNSON & JOHNSON Founded in - 1886 Revenue - $61.9 billion(2009) Operating Income - $15.7 billion(2009) Employee’s - 118,700 (2009)

23. MAIN PRODUCTIONS AREAS INCLUDE Medical devices Health care products Toiletries Soaps Shampoos

24. POSITIONING OF MEDICINE FOR DIABETES CANAGLIFLOZIN is the main Product. For Oral Type 2 diabetes. Promote Weight Loss in Treatment of Type 2 Diabetes.

25. PFIZER Founded in - 1849 Revenue - $50.0 billion(2009) Net Income - $8.63 billion(2009) Employee’s - 116,500 (2009) Ranked No. 2 in sales

26. MAIN PRODUCTIONS AREAS INCLUDE Lipitor( to lower blood cholesterol) Lyrica(neuropathic drug) Diflucan(the oral antifungal) Antibiotic Zithromax.

27. POSITIONING OF MEDICINE FOR DIABETES EXUBERA for diabetes and Insulin Therapies Exubera is an Inhaled Insulin for Type 1 and Type 2 Diabetes Many drugs can interfere with Exubera.

28. GLAXO SMITH KLINE Founded in - 2000 Revenue- £28.36billion(2009) Net Income - £5.66 billion (2009) Employee’s - 99,000 (2009) Ranked No. 1 in sales

29. MAIN PRODUCTIONS AREAS INCLUDE Asthma Cancer Virus control Mental health Diabetes and Digestive conditions

30. POSITIONING OF MEDICINE FOR DIABETES AVANDIA is the main product for diabetes. Oral Drug. To treat Type-2 diabetes. Increase the risk of Heart attack, Strokes, Fractures, Eye damage.

31. ASTRA ZENECA Founded in - 2000 Revenue -$32,804 million(2009) Net Income - $7,544 million(2009) Employee’s - 116,500 (2009)

32. MAIN PRODUCTIONS AREAS INCLUDE Cancer Cardiovascular Gastrointestinal infection Neuroscience Respiratory disorder Inflammation. THEY HAVE NO PRODUCT FOR DIABETES.

33. MAJOR COMPETITORS IN BRAZIL Atlanta Pharmaceuticals. Bayer’s Pharmaceuticals. Novartis Pharmaceuticals. Roche Pharmaceuticals. Ache Laboratories Pharmaceuticals.

34. BAYER’S PHARMACEUTICALS Founded in - 1863 Revenue - €31.17billion(2009) Net Income - €3.0 billion (2009) Employee’s - 108,400 (2009)

35. MAIN PRODUCTIONS AREAS INCLUDE Veterinary drugs General and specialty medicines Women's health products Over-the-counter drugs Diabetes care

36. PRODUCT FOR DIABETES Bayer’s Contour USB Meter for measuring Blood Glucose. Bayer’s Entrust for measuring Blood Glucose.

37. NOVARTIS PHARMACEUTICALS Founded in - 1996 Revenue - $44.27billion(2009) Net Income - $8.40 billion (2009) Employee’s - 99,830

38. MAIN PRODUCTIONS AREAS INCLUDE Pharmaceuticals Generic drugs Over-the-counter drugs Vaccines Contact lenses

39. POSITIONING FOR DIABETES Novartis resource Diabetishield A Nutritional drink formulated for Individuals with Diabetes. Added arginine, chromium, and vitamins C and E help to improve insulin sensitivity and aid in blood sugar control.

40. ROCHE PHARMACEUTICALS Founded in - 1896 Revenue - CHF 49.05billion(2009) Net Income - CHF 12.28 billion (2009) Employee’s - 81,500 (2009)

41. MAIN PRODUCTIONS AREAS INCLUDE Pharmaceuticals Xenical(Obesity) Zenapax(Monoclonal Antibody) Valcyte(Antiviral) Bactrim (Antibiotic) Tamiflu (Antiviral) Diagnostics

42. POSITIONING FOR DIABETES Accu-Chek is the brand of blood sugar -testing device. Include- Accu-Chek Aviva Accu-Chek Compact Plus

43. ACHE LABORATORIES PHARMACEUTICALS Founded in - 1974 The best pharmaceutical lab in Brazil. Employee’s - 3,000

45. Preferred by consumers and health professionals.

47. Creativity and convenience.

48. Innovative and accessible products and services that promote consumer health and well being.

50. Respect to People

51. Respect to the Environment

52. Enterprising Spirit

53. Innovation

55. BOEHRINGER INGELHEIM Founded in - 1885 Revenue - €11.595 billion (2008) Net Income - €1.424 billion (2008) Employee’s - 41,300 (2008)

57. Healthcare productsBiopharmaceuticals Chemicals Animal health products

58. POSITIONING FOR DIABETES LINAGLIPTIN is the main product. Effective against Type-II Diabetes. Oral Medicine. Still under trial.

59. MERCK KGAA Founded in - 1668 Revenue - €7.747 billion (2009) Operative Income - €620.9 million (2009) Employee’s - 40,507 (2010)

60. MAIN PRODUCTION AREAS Liquid crystals Life science and performance chemicals Over-the-counter medicines Small molecules Biopharmaceuticals

61. POSITIONING FOR DIABETES JANUVIA is drug which works for the management of Type 2 diabetes. Oral Medicine. Side Effects- severe pain in stomach nausea and vomiting, loss of appetite, fast heart rate, fever, sore throat.

62. BAYER SCHERING PHARMA Founded in - 2006 Revenue - €10.267 billion (2007) Employee’s- 26,000 (2004) Headquarter - Germany

63. MAIN PRODUCTION AREAS Gynaecology & Andrology Special therapeutics Diagnostical devices Nuclear medicine Oncology

64. POSITIONING FOR DIABETES Launched SciLin a recombinant insulin product, in China. Oral Drug for Adults.

65. COMPETITORS IN INDIA Ranbaxy (Daiichi) Dr. Reddy’s Laboratories Cipla Sun Pharma AurobindoPharma

66. RANBAXY (DAIICHI) Founded in - 1961 Revenue - US$ 1,405 million (2010) Net Income - US$ 349 million (2010) Employee’s - 1,100 in R & D Operating in over - 125 Countries Market Share in India - 4.9%

67. MAIN PRODUCTION AREAS Cardiovascular Central Nervous System Respiratory Dermatology Orthopedics Nutritionals Urology

68. POSITIONING FOR DIABETES VOLIX (VOGLIBOSE) is the main product for Treatment Of Diabetes. Help in improving of Postprandial Hyperglycemia in Diabetes Mellitus. Oral Drug. Will Launch anti-diabetic drug ACTOS in the US by 2012.

69. Dr. REDDY’S LABORATORIES Founded in - 1984 Revenue - US$ 1.5 billion (2007) Net Income - US$ 216 million (2007) Employee’s - 8,225 Major seller in Europe, Canada and Russian. Number one in India in terms of profitability.

72. MAIN PRODUCTION AREAS Cancer Diabetes Cardiovascular disease Inflammation Bacterial infection

73. POSITIONING FOR DIABETES BALAGLITAZONE is the main product for Diabetes. First lead molecule in anti-diabetic segment. RAGAGLITAZONE is a new product & is more promising.

74. CIPLA Founded in - 1935 Revenue - US$ 1.28 billion (2010) Net Income - US$ 245.7 million (2010) Employee’s - 7,000 2nd Largest Pharmaceutical Company in India in terms of retail sales.

75. Operating in 170 Countries.

76. MAIN PRODUCTION AREAS Pharmaceuticals Animal Health Care Products OTC (Over The Counter) Drug Bulk Drugs Flavours& Fragrances Agrochemicals

77. POSITIONING FOR DIABETES ACARBOSE is main product used for type 2 diabetes mellitus. Oral Medicine. Side Effects- Diarrhea, Hypoglycemia, Dizziness, Headache.

78. SUN PHARMA Founded in - 1983 Revenue - Rs 42.7 billion (2009) Net Income - Rs 18.7 billion (2009) Employee’s - 8,000 (2008)

79. MAIN PRODUCTION AREAS Anticancer Analgesics Antidepressant Antidiabetic Antihypertensive Cardiovascular

80. POSITIONING FOR DIABETES GLIMEPRIDE & METFORMINE are the main drugs. Used for Type 2 Diabetes. Oral Medicine for Adults.

81. COMPETITOR’S IN AUSTRALIA Novogen Amrad Corporation Biota Holdings Ltd. Novo Nordisk Pfizer Australia

82. COMPETITOR’S IN JAPAN Daiichi Sankyo Co. Astellas Chugai Pharma Eisai Co. Takeda Pharma

83. DAIICHI SANKYO COMPANY Founded in - 2005 Revenue - ¥ 880,120 million (2007) Net Income - ¥ 97,660 million (2007) Employee’s - 15,349 (2008)

84. DIFFERENT PRODUCTS Cravit Evoxac FloxinOtic Gracevit Rivoglitazone—Type 2 Diabetes. It is still under trial.

85. EISAI COMPANY Founded in - 1936 Revenue - ¥ 781.7 billion (2008) Net Income - ¥ 47.7 billion (2008) Employee’s - 10,962 (2008)

86. DIFFERENT PRODUCTS Aciphex/Pariet(Gastroesophageal reflux disease) Actonel (Osteoporosis) Methylcobal(Peripheral Neuropathy) Myonal (Muscle relaxant) AS-3201 (Diabetic neuropathy)

87. ASTELLAS PHARMA Founded in - 2005 Revenue - ¥ 972.6 billion (2007) Net Income - ¥ 177.4 billion (2007) Employee’s - 13,900 (2007)

88. DIFFERENT PRODUCTS Prograf (Prevention of post- transplant organ rejection) Protopic (Atopic dermatitis) AmBisome (Anti-fungal) Mycamine(Anti-fungal)

89. THANK YOU AMARJIT SINGH